Insider Transactions in Q2 2019 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2019
|
Robert M Davis Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
216,718
-34.92%
|
$18,421,030
$85.67 P/Share
|
|
Jun 25
2019
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
216,718
+37.95%
|
-
|
|
May 10
2019
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-3.0%
|
$168,636
$78.33 P/Share
|
|
May 10
2019
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
4,389
+5.75%
|
-
|
|
May 10
2019
|
Michael Fleming SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-15.59%
|
$40,326
$78.33 P/Share
|
|
May 10
2019
|
Michael Fleming SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,509
+31.27%
|
-
|
|
May 10
2019
|
Michael Nally EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-11.79%
|
$40,248
$78.33 P/Share
|
|
May 10
2019
|
Michael Nally EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,811
+29.27%
|
-
|
|
May 10
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,622
-7.24%
|
$126,516
$78.33 P/Share
|
|
May 10
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
3,292
+12.81%
|
-
|
|
May 07
2019
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Open market or private sale
|
Direct |
25,000
-27.0%
|
$1,925,000
$77.73 P/Share
|
|
May 07
2019
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+21.26%
|
$975,000
$39.29 P/Share
|
|
May 06
2019
|
Kenneth C Frazier Executive Chair |
SELL
Bona fide gift
|
Direct |
14,623
-1.83%
|
-
|
|
May 04
2019
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
938
-1.37%
|
$75,040
$80.0 P/Share
|
|
May 04
2019
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,904
+2.7%
|
-
|
|
May 04
2019
|
Michael Nally EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
370
-12.61%
|
$29,600
$80.0 P/Share
|
|
May 04
2019
|
Michael Nally EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,298
+30.66%
|
-
|
|
May 04
2019
|
Jennifer Zachary EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,154
-37.32%
|
$172,320
$80.0 P/Share
|
|
May 04
2019
|
Jennifer Zachary EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,772
+50.0%
|
-
|
|
May 04
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-3.03%
|
$47,760
$80.0 P/Share
|
|
May 04
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,212
+5.79%
|
-
|
|
May 04
2019
|
Michael Fleming SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-11.64%
|
$19,040
$80.0 P/Share
|
|
May 04
2019
|
Michael Fleming SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
692
+25.28%
|
-
|
|
May 03
2019
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
35,000
-33.0%
|
$2,800,000
$80.0 P/Share
|
|
May 03
2019
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+24.81%
|
$1,365,000
$39.29 P/Share
|